FindTrial
Sign In

Efficacy and safety of a new nasopharyngeal airway versus nasal oxygen tube for endoscopy in obese patients under intravenous anesthesia: a prospective, single-center, phase II, parallel, randomized, controlled study

Efficacy and safety of a new nasopharyngeal airway versus nasal oxygen tube for endoscopy in obese patients under intravenous anesthesia: a prospective, single-center, phase II, parallel, randomized, controlled study

Status
Active, not recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2100051545
Enrollment
Unknown
Registered
2021-09-26
Start date
2021-10-01
Completion date
Unknown
Last updated
2022-06-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

stomach neoplasm

Interventions

Nasopharyngeal airway group:Insert the nasopharyngeal airway
Nasal oxygen tube group:Put in a nasal oxygen tube

Sponsors

Taizhou Cancer Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1. Patients over 18 years old who are planning to undergo painless gastroscopy; 2. Body Mass Index (BMI, Body Mass Index)> 28kg/m2.

Exclusion criteria

Exclusion criteria: 1. Patients with severe cardiac and pulmonary insufficiency; 2. Nasal airway obstruction, nasal bone fracture, obvious nasal septum deviation; 3. Obvious abnormal blood coagulation function; 4. Traumatic brain injury; 5. Cerebrospinal fluid rhinorrhea.

Design outcomes

Primary

MeasureTime frame
Incidence of hypoxemia in anesthesia;blood oxygen saturation;—

Countries

China

Contacts

Public ContactHe Qingquan

Taizhou Cancer Hospital

780009569@qq.com+86 13676668531

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026